Hostname: page-component-8448b6f56d-dnltx Total loading time: 0 Render date: 2024-04-20T01:35:55.829Z Has data issue: false hasContentIssue false
  • English
  • Français

A Clinical and Biochemical Study of Monoamine Oxidase Inhibition in Depressed Patients

I. a Clinical Trial of Nialamide

Published online by Cambridge University Press:  08 February 2018

W. G. Dewhurst  and
C. M. B. Pare
W. G. Dewhurst
Affiliation:
Bethlem Royal and The Maudsley Hospitals
C. M. B. Pare
Affiliation:
Bethlem Royal and The Maudsley Hospitals
Get access Rights & Permissions [Opens in a new window]

Extract

The discovery that iproniazid benefits certain subjects with depression, linked with the demonstration that it inhibits the enzyme monoamine oxidase (MAO), led to the hypothesis that inhibition of MAO was the essential mechanism by which iproniazid caused relief of symptoms (Pletscher, 1959). Iproniazid, unfortunately, can produce serious toxic effects, particularly on the liver (Pare and Sandler, 1959), and this has limited its clinical application. For this reason a search has been made for MAO inhibitors with an effective anti-depressant action yet without the serious toxic effects of iproniazid. Among the newer compounds for which such claims have been made is N-isonicotinoyl (-N-N-benzylcarboxamidoethyl) hydrazine or Nialamide.

Type
Original Articles
Information
Journal of Mental Science , Volume 107 , Issue 447 , March 1961 , pp. 239 - 243
Copyright
Copyright © Royal College of Psychiatrists, 1961 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Pare, C. M. B., and Sandler, M., Lancet, 1959, i, 282.CrossRefGoogle Scholar
Iidem, J. Neurol. Neurosurg. Psychiat., 1959, 22, 247.Google Scholar
Pletscher, A., Ann. N. Y. acad. Sci., 1959, 80, 1039.Google Scholar
Reitman, S., and Frankel, S., Amer. J. clin. Path., 1957, 28, 56.Google Scholar
“Symposium on the Biochemical and Clinical Aspects of Marsilid and other Monoamine Oxidase Inhibitors”, J. clin. exp. Psychopath., 1958, 19, suppl. 1.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.